亚太地区二尖瓣与三尖瓣瓣中瓣/瓣中环注册登记研究 (AP ViV)
亚太地区二尖瓣与三尖瓣瓣中瓣/瓣中环注册表
A significant number of patients with severe mitral and tricuspid valve disease have been previously treated with either valve repair with annuloplasty rings or valve replacement with bioprosthetic/mechanical valves. Over time, these bioprosthetic valves and rings may fail resulting in recurrence of the valvular disease. The technical aspects of a re-do operation are complex and these patients are often times at high risk for repeat open surgery. The emergence of transcatheter options may provide a safer and less invasive alternative to open surgery. Majority of the data currently exist for Western cohorts with limited longer-term outcomes. Data on this therapy is particularly lacking in the Asia-Pacific region, especially important in the light of known differences in body habitus and size.
研究概览
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Chak Yu Kent So
- 电话号码:852-35051518
- 邮箱:scy309@ha.org.hk
学习地点
-
-
Shatin
-
Hong Kong、Shatin、香港、0000
- 招聘中
- Prince of Wales Hospital
-
接触:
- Chak Yu So
- 电话号码:85235051518
- 邮箱:scy309@ha.org.hk
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
This is a retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific from 1 Jan 2023 to 31 Dec 2035.
描述
Inclusion Criteria:
- Age ≥ 21
- Had at least one documented Mitral valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Mitral valve-in-valve/valve-in-ring procedure. (Prospective) OR Had at least one documented Tricuspid valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Tricuspid valve-in-valve/valve-in-ring procedure. (Prospective)
Exclusion Criteria:
- Active endocarditis
- Any other conditions which investigator deems unsuitable for participation.
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:OTHER
队列和干预
团体/队列 |
|---|
|
Prospective
Patient planned to undergo a Mitral valve-in-valve/valve-in-ring procedure. |
|
Retrospective
Patient that had at least one documented Mitral valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
All-cause mortality
大体时间:10 years
|
Rate of All-cause mortality in enrolled patients |
10 years
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Procedural technical success rate
大体时间:Immediately after operation
|
Rate of Procedural technical success (defined per Mitral Valve Academic Research Consortium (MVARC) criteria at exit from the hybrid suite as patient alive with successful access, delivery, and retrieval of the device delivery system, successful deployment and correct position of the first intended device, and freedom from emergency surgery or reintervention associated with the device or access procedure) |
Immediately after operation
|
|
Procedural complication rate
大体时间:Periprocedural
|
Rate of Procedural technical success (defined per Mitral Valve Academic Research Consortium (MVARC) criteria at exit from the hybrid suite as patient alive with successful access, delivery, and retrieval of the device delivery system, successful deployment and correct position of the first intended device, and freedom from emergency surgery or reintervention associated with the device or access procedure) |
Periprocedural
|
|
Major adverse cardiovascular events rate
大体时间:10 years
|
Rate of Major adverse cardiovascular events in enrolled patients |
10 years
|
|
New York Heart Association (NYHA) classification
大体时间:10 years
|
NYHA class of enrolled patients |
10 years
|
|
Echocardiographic result
大体时间:10 years
|
Rate of Major adverse cardiovascular events in enrolled patients |
10 years
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.